📣 For more lifestyle news, click here to join our WhatsApp Channel and also follow us on Instagram
Antibiotic resistance – it’s a term we hear thrown around, but what does it mean for our health? With the rise of superbugs, and bacteria that shrug off our strongest antibiotics, the future of treating common infections seems uncertain.
However, there’s hope! The World Health Organization (WHO, this week, took a critical step in the fight against antimicrobial resistance (AMR) by updating their Bacterial Priority Pathogens List (BPPL).
This might sound like a scientific technicality, but according to Dr Rahul Agarwal, Consultant Internal Medicine at CARE Hospitals Hitech City, Hyderabad, it’s a crucial step in the fight against this growing health threat.
Let’s delve deeper into what this update signifies and how it can impact your everyday life. We’ll explore the purpose of the BPPL, the latest changes, and most importantly, what you can do to safeguard yourself and your loved ones from these increasingly resistant pathogens.
Dr Agarwal explained that the BPPL is a critical tool. Here’s why:
Purpose: The BPPL guides research and development (R&D) efforts for new antibiotics, ensuring we have effective treatments available in the future.
Importance: AMR occurs when bacteria, viruses, and other microbes become resistant to the drugs designed to kill them. This can lead to increased illness, longer hospital stays, and even death. The misuse and overuse of antibiotics are major contributors to AMR.
The updated list categoriess 15 families of antibiotic-resistant bacteria into three priority groups, Dr Agarwal said:
Critical Priority: These pose the most significant threat and include:
Gram-negative bacteria (e.g., Acinetobacter baumannii) which can easily develop resistance and spread it to others.
Mycobacterium tuberculosis resistant to the antibiotic rifampicin, a concern for tuberculosis treatment.
High Priority: These pathogens pose major challenges, especially in healthcare settings, such as:
Vancomycin-resistant Enterococcus faecium, a hospital-acquired infection.
Methicillin-resistant Staphylococcus aureus (MRSA), a common antibiotic-resistant infection.
Medium Priority: These pathogens cause a high disease burden and require attention, particularly in vulnerable populations. New additions to the 2024 list include Group A and B Streptococci.
Dr Agarwal emphasised that everyone can play a role in combating AMR:
By understanding the BPPL update and following these simple steps, you can contribute to the global fight against AMR and ensure effective treatments are available for future generations.